Article · 4 May 2026
ArticlePublished 7 Aug 2024
Investigation of the Mechanism of silencing microRNA-665 Expression in Depression via the Phosphoinositide 3-Kinase/Protein Kinase B/c-Jun N-Terminal Kinase Pathway
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
This study explores the consequences of microRNA-665 suppression on depression, shedding light on the mechanisms involved through the phosphoinositide 3-kinase/protein kinase B/c-Jun N-terminal kinase signaling pathways. The findings aim to identify new therapeutic targets and offer deeper insights for treating depression. To model depression, mice were subjected to a chronic unpredictable mild stress protocol and subsequently distributed randomly into four groups; control, depression model, microRNA-665 silencing, and microRNA-665 silencing combined with phosphoinositide 3-kinase/protein kinase B inhibitor. MicroRNA-665 expression was silenced using adenoviral vectors. Serum cortisol levels were measured using enzyme-linked immunosorbent assay. In the depression model, silencing microRNA-665 notably decreased immobility duration in both the forced swim test and the tail suspension test. Additionally, it led to a significant increase in the total movement distance observed in the open field test. Enzyme-linked immunosorbent assay results showed a decrease in serum cortisol levels in the microRNA-665 silencing group. Reverse transcription-quantitative polymerase chain reaction analysis indicated that silencing microRNA-665 regulated the expression levels of phosphoinositide 3-kinase, protein kinase B, and c-Jun N-terminal kinase genes towards normal levels. Silencing miR-665 expression significantly improved the behavioral performance of depressed mice and normalized the levels of associated proteins and genes through the phosphoinositide 3-kinase, protein kinase B, and c-Jun N-terminal kinase signaling pathways, as well as regulated physiological indicators associated with depression.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Indian Journal of Pharmaceutical Sciences.
Article · 21 Apr 2026
In silico molecular docking analysis of bioactive compounds from Kappaphycus alvarezii and Gracilaria debilis against BRCA1 protein
Article · 11 Mar 2026
Trimethoprim and Sulfamethoxazole-Loaded Nanoparticles Coated With Chitosan for Intranasal Delivery to Treat Cerebral Toxoplasmosis
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalIndian Journal of Pharmaceutical Sciences
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Fei Gao”
- BylineArticles whose byline prints “Liangsong Li”
- BylineArticles whose byline prints “Qian Hu”
- BylineArticles whose byline prints “Dechen Wang”